Walleye Capital LLC Astrazeneca PLC Call Options Transaction History

Walleye Capital LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$66.81 - $80.83 $8.06 Million - $9.75 Million	-120,600 Reduced 58.37%	86,000 $6.71 Million
Q1 2024 May 15, 2024	SELL	$61.03 - $69.57 $1.93 Million - $2.21 Million	-31,700 Reduced 13.3%	206,600 $14 Million
Q4 2023 Feb 14, 2024	BUY	$61.89 - $69.28 $3.42 Million - $3.82 Million	55,200 Added 30.15%	238,300 $16 Million
Q3 2023 Nov 14, 2023	BUY	$64.85 - $71.7 $4.22 Million - $4.66 Million	65,000 Added 55.04%	183,100 $12.4 Million
Q2 2023 Aug 14, 2023	BUY	$69.91 - $75.81 $4.76 Million - $5.16 Million	68,100 Added 136.2%	118,100 $8.45 Million
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $2.79 Million - $3.16 Million	44,200 Added 762.07%	50,000 $3.47 Million
Q4 2022 Feb 14, 2023	SELL	$54.21 - $70.44 $2.56 Million - $3.32 Million	-47,200 Reduced 89.06%	5,800 $393,000
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $2.81 Million - $7.19 Million	53,000 New	53,000 $2.91 Million

1,343

492M

4.99M

3.19M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $233B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.